The immunomodulatory role of Regnase family RNA-binding proteins

References

• Gerstberger S, Hafner M, Tuschl T. A census of human RNA-binding proteins. Nat Rev Genet. 2014;15(12):829–845.
   PubMed Web of Science ®Google Scholar
• Yoshinaga M, Takeuchi O. RNA binding proteins in the control of autoimmune diseases. ImmunolMed. 2019;42(2):53–64.
   Google Scholar
• de Bruin RG, Rabelink TJ, van Zonneveld AJ, et al. Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease. Eur Heart J. 2017;38(18):ehw567.
   Web of Science ®Google Scholar
• Akira S. Regnase-1, a ribonuclease involved in the regulation of immune responses. Cold Spring Harb Symp Quant Biol. 2013;78(1):51–60.
   PubMedGoogle Scholar
• Cui X, Mino T, Yoshinaga M, et al. regnase-1 and roquin nonredundantly regulate Th1 differentiation causing cardiac inflammation and fibrosis. J Immunol. 2017;ji1701211. DOI:10.4049/jimmunol.1701211
   Web of Science ®Google Scholar
• King KR, Aguirre AD, Ye YX, et al. IRF3 and type i interferons fuel a fatal response to myocardial infarction. Nat Med. 2017;23(12):1481–1487.
   PubMed Web of Science ®Google Scholar
• Mino T, Takeuchi O. Post-transcriptional regulation of immune responses by RNA binding proteins. Proc Jpn Acad Ser B. 2018;94(6):248–258.
   PubMed Web of Science ®Google Scholar
• Jura J, Skalniak L, Koj A. Monocyte chemotactic protein-1-induced protein-1 (MCPIP1) is a novel multifunctional modulator of inflammatory reactions. Biochim Biophys Acta Mol Cell Res. 2012;1823(10):1905–1913.
   Web of Science ®Google Scholar
• Liang J, Wang J, Azfer A, et al. A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. J Biol Chem. 2008;283(10):6337–6346.
   PubMed Web of Science ®Google Scholar
• Anderson P. Post-transcriptional control of cytokine production. Nat Immunol. 2008;9(4):353–359.
   PubMed Web of Science ®Google Scholar
• Shyu A-B, Wilkinson MF, van Hoof A. Messenger RNA regulation: to translate or to degrade. Embo J. 2008;27(3):471–481.
   PubMed Web of Science ®Google Scholar
• Mino T, Murakawa Y, Fukao A, et al. Regnase-1 and roquin regulate a common element in inflammatory mRNAs by spatiotemporally distinct mechanisms. Cell. 2015;161(5):1058–1073.
   PubMed Web of Science ®Google Scholar
• Matsushita K, Takeuchi O, Standley DM, et al. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature. 2009;458(7242):1185–1190.
   PubMed Web of Science ®Google Scholar
• Liang J, Saad Y, Lei T, et al. MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling. J Exp Med. 2010;207(13):2959–2973.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang T, Jiang L, et al. MCP-induced protein 1 attenuates sepsis-induced acute lung injury by modulating macrophage polarization via the JNK/c-Myc pathway. Int Immunopharmacol. 2019;75(April):105741.
   PubMedGoogle Scholar
• Nakatsuka Y, Vandenbon A, Mino T, et al. Pulmonary Regnase-1 orchestrates the interplay of epithelium and adaptive immune systems to protect against pneumonia. Mucosal Immunol. 2018;March:1–16. DOI:10.1038/s41385-018-0024-5
   Google Scholar
• Takaishi M, Satoh T, Akira S, et al. Regnase-1, an immunomodulator, limits the IL-36/IL-36R autostimulatory loop in keratinocytes to suppress skin inflammation. J Invest Dermatol. 2018;138(6):1439–1442.
   PubMed Web of Science ®Google Scholar
• Uehata T, Iwasaki H, Vandenbon A, et al. XMalt1-induced cleavage of regnase-1 in CD4+ helper T cells regulates immune activation. Cell. 2013;153(5):1036.
   PubMed Web of Science ®Google Scholar
• Wei J, Long L, Zheng W, et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019;576(7787):471–476.
   PubMed Web of Science ®Google Scholar
• Lin R-J, Chu J-S, Chien H-L, et al. MCPIP1 suppresses hepatitis C virus replication and negatively regulates virus-induced proinflammatory cytokine responses. J Immunol. 2014;193(8):4159–4168.
   PubMed Web of Science ®Google Scholar
• Lin RJ, Chien HL, Lin SY, et al. MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation. Nucleic Acids Res. 2013;41(5):3314–3326.
   PubMed Web of Science ®Google Scholar
• Pichlmair A, Diebold SS, Gschmeer S, et al. Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via toll-like receptor 9. J Virol. 2007;81(2):539–547.
   PubMed Web of Science ®Google Scholar
• Pichlmair A, Reis E Sousa C. Innate recognition of viruses. Immunity. 2007;27(3):370–383.
   PubMed Web of Science ®Google Scholar
• Kidoya H, Muramatsu F, Shimamura T, et al. Regnase-1-mediated post-transcriptional regulation is essential for hematopoietic stem and progenitor cell homeostasis. Nat Commun. 2019;10:1.
   PubMed Web of Science ®Google Scholar
• Iwasaki H, Takeuchi O, Teraguchi S, et al. The IκB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1. Nat Immunol. 2011;12(12):1167–1175.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Arima Y, Kamimura D, et al. Phosphorylation-dependent Regnase-1 release from endoplasmic reticulum is critical in IL-17 response. J Exp Med. 2019;216(6):1431–1449.
   PubMed Web of Science ®Google Scholar
• Matsushita K, Tanaka H, Yasuda K, et al. Regnase-1 degradation is crucial for interleukin-33- and interleukin-25-mediated ILC2 activation. JCI Insight. 2020. DOI:10.1172/jci.insight.131480
   PubMed Web of Science ®Google Scholar
• Niu J, Shi Y, Xue J, et al. USP10 inhibits genotoxic NF-κB activation by MCPIP1-facilitated deubiquitination of NEMO. Embo J. 2013;32(24):3206–3219.
   PubMed Web of Science ®Google Scholar
• Liang J, Song W, Tromp G, et al. Genome-wide survey and expression profiling of CCCH-zinc finger family reveals a functional module in macrophage activation. PLoS ONE. 2008;3:8.
   Web of Science ®Google Scholar
• Wawro M, Wawro K, Kochan J, et al. ZC3H12B/MCPIP2, a new active member of the ZC3H12 family. RNA. 2019;25(7):840–856.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhou Z, Huang S, et al. Zc3h12c inhibits vascular inflammation by repressing NF-κB activation and pro-inflammatory gene expression in endothelial cells. Biochem J. 2013;451(1):55–60.
   PubMedGoogle Scholar
• von Gamm M, Schaub A, Jones AN, et al. Immune homeostasis and regulation of the interferon pathway require myeloid-derived Regnase-3. J Exp Med. 2019;216(7):1700–1723.
   PubMed Web of Science ®Google Scholar
• Tsoi LC, Spain SL, Trembath RC. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet. 2012;44(12):1341–1348. https://doi.org/10.1038/ng. 2467
   Google Scholar
• Huang W-Q, Yi K-H, Li Z, et al. DNA methylation profiling reveals the change of inflammation-associated ZC3H12D in leukoaraiosis. Front Aging Neurosci. 2018;10(MAY):1–18.
   PubMedGoogle Scholar
• Minagawa K, Wakahashi K, Kawano H, et al. Posttranscriptional modulation of cytokine production in T cells for the regulation of excessive inflammation by TFL. J Immunol. 2014;192(4):1512–1524.
   PubMed Web of Science ®Google Scholar
• Huang S, Qi D, Liang J, et al. The putative tumor suppressor Zc3h12d modulates toll-like receptor signaling in macrophages. Cell Signal. 2012;24(2):569–576.
   PubMed Web of Science ®Google Scholar
• Zhang H, WC W, JK C, et al. ZC3H12D attenuated inflammation responses by reducing mRNA stability of proinflammatory genes. Mol Immunol. 2015;67(2):206–212.
   PubMed Web of Science ®Google Scholar
• Huang S, Liu S, Fu JJ, et al. Monocyte chemotactic protein-induced protein 1 and 4 form a complex but act independently in regulation of interleukin-6 mRNA degradation. J Biol Chem. 2015;290(34):20782–20792.
   PubMed Web of Science ®Google Scholar
• Bloch DB, Nobre R. p58TFL does not localize to messenger RNA processing bodies. Mol Cancer Res. 2010;8(1):131–132.
   PubMedGoogle Scholar
• Minagawa K, Yamamoto K, Nishikawa S, et al. Deregulation of a possible tumour suppressor gene, ZC3H12D, by translocation of IGK@ in transformed follicular lymphoma with t(2;6)(p12;q25). Br J Haematol. 2007;139(1):161–163.
   PubMed Web of Science ®Google Scholar
• Wawro M, Kochan J, Krzanik S, et al. Intact NYN/PIN-like domain is crucial for the degradation of inflammation-related transcripts by ZC3H12D. J Cell Biochem. 2017;118(3):487–498.
   PubMed Web of Science ®Google Scholar
• Kakiuchi N, Yoshida K, Uchino M, et al. Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis. Nature. 2020;577(7789):260–265.
   PubMed Web of Science ®Google Scholar
• Nanki K, Fujii M, Shimokawa M, et al. Somatic inflammatory gene mutations in human ulcerative colitis epithelium. Nature. 2020;577(7789):254–259.
   PubMed Web of Science ®Google Scholar
• Nagahama Y, Shimoda M, Mao G, et al. Regnase-1 controls colon epithelial regeneration via regulation of mTOR and purine metabolism. Proc Nat Acad Sci. 2018;115(43):11036–11041.
   PubMed Web of Science ®Google Scholar
• Yoshinaga M, Nakatsuka Y, Vandenbon A, et al. (2017). Regnase-1 maintains iron homeostasis via the degradation of transferrin receptor 1 and Prolyl-hydroxylase-domain-containing protein 3 mRNAs. Cell Rep. 1614–1630;19(8). DOI:10.1016/j.celrep.2017.05.009
   Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–1131.
   PubMed Web of Science ®Google Scholar
• Everett BM, Pradhan AD, Solomon DH, et al. Rationale and design of the cardiovascular inflammation reduction trial: a test of the inflammatory hypothesis of atherothrombosis. Am Heart J. 2013;166(2):199–207.e15.
   PubMed Web of Science ®Google Scholar